Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oncolytics Biotech enters reovirus development agreement

June 3, 1999

Mitsubishi Chemical group describes inhibitors of EGF TK and tumor cell proliferation

June 2, 1999

Licensing opportunity from Fox Chase Cancer Center: MDR-reversing agents

June 2, 1999

Bavarian Nordic's tyrosinase vector enters safety study in Germany

June 2, 1999

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

June 1, 1999

Novel matrix metalloproteinase inhibitor selectively inhibits rat osteosarcoma lung metastasis

June 1, 1999

Imidazole-based protein farnesyltransferase inhibitors for cancer

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

June 1, 1999

Recombinant enzyme plus gene therapy: a unique combination therapy for cancer

May 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...